PD-L1 Expression and Its Clinical Relevance in Neuroendocrine Tumors of the Lung

被引：0
|
作者：
Kasajima, A. [1 ]
Ishikawa, Y. [2 ]
Iwata, A. [3 ]
Steiger, K. [4 ]
Oka, N. [3 ]
Sakurada, A. [5 ]
Suzuki, H. [6 ]
Konukiewitz, B. [1 ]
Kloeppel, G. [1 ]
Okada, Y. [5 ]
Sasano, H. [7 ]
Weichert, W. [1 ]
机构：
[1] Tech Univ Munich, Dept Pathol, Munich, Germany
[2] JFCR, Canc Inst Hosp, Dept Pathol, Tokyo, Japan
[3] Tohoku Univ, Grad Sch Med, Dept Pathol, Sendai, Miyagi, Japan
[4] Tech Univ Munche, Dept Pathol, Munich, Germany
[5] Tohoku Univ, Grad Sch Med, Dept Thorac Surg, Sendai, Miyagi, Japan
[6] Natl Hosp Org, Sendai Med Ctr, Sendai, Miyagi, Japan
[7] Dept Pathol, Sendai, Miyagi, Japan
来源：
NEUROENDOCRINOLOGY | 2018年 / 106卷
关键词：
lung nen; pd-l1; prognosis;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
M05
引用
收藏
页码：290 / 290
页数：1
相关论文
共 50 条
  • [1] PD-L1 expression in neuroendocrine tumors of the lung
    Tsuruoka, Kenjiro
    Horinouchi, Hidehito
    Goto, Yasushi
    Kanda, Shintaro
    Fujiwara, Yutaka
    Nokihara, Hiroshi
    Yamamoto, Noboru
    Asakura, Keisuke
    Nakagawa, Kazuo
    Sakurai, Hiroyuki
    Watanabe, Shun-ichi
    Tsuta, Koji
    Ohe, Yuichiro
    LUNG CANCER, 2017, 108 : 115 - 120
  • [2] PD-L1 Expression in Neuroendocrine Tumors of the Lung
    Tsuruoka, Kenjiro
    Horinouchi, Hidehito
    Goto, Yasushi
    Kanda, Shintaro
    Fujiwara, Yutaka
    Nokihara, Hiroshi
    Yamamoto, Noboru
    Watanabe, Shun-Ichi
    Tsuta, Koji
    Ohe, Yuichiro
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S509 - S509
  • [3] The Pattern of PD-L1 Expression in Thoracic Neuroendocrine Tumors
    Karim, N.
    Pathrose, J.
    El Desouki, I.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S971 - S972
  • [4] PD-L1 Expression Is Associated with Grade of Neuroendocrine Tumors
    Li, Z.
    Leng, J.
    Wang, H.
    Li, S.
    Lu, M.
    Zhou, L.
    Huang, X.
    Jia, L.
    Kang, Q.
    Li, J.
    Shen, L.
    Lin, D.
    NEUROENDOCRINOLOGY, 2016, 103 : 39 - 40
  • [5] Inflammation and PD-L1 expression in pulmonary neuroendocrine tumors
    Kasajima, Atsuko
    Ishikawa, Yuichi
    Iwata, Ayaka
    Steiger, Katja
    Oka, Naomi
    Ishida, Hirotaka
    Sakurada, Akira
    Suzuki, Hiroyoshi
    Kameya, Toru
    Konukiewitz, Bjoern
    Kloeppel, Guenter
    Okada, Yoshinori
    Sasano, Hironobu
    Weichert, Wilko
    ENDOCRINE-RELATED CANCER, 2018, 25 (03) : 339 - 350
  • [6] PD-L1 Expression in Pituitary Neuroendocrine Tumors/Pituitary Adenomas
    Cossu, Giulia
    La Rosa, Stefano
    Brouland, Jean Philippe
    Pitteloud, Nelly
    Harel, Ethan
    Santoni, Federico
    Brunner, Maxime
    Daniel, Roy Thomas
    Messerer, Mahmoud
    CANCERS, 2023, 15 (18)
  • [7] PD-L1, MMR, and EGFR expression in gastrointestinal neuroendocrine tumors
    Karabag, Sevil
    Oznur, Meltem
    CUKUROVA MEDICAL JOURNAL, 2024, 49 (02): : 400 - 406
  • [8] PD-1 and PD-L1 expression in rare lung tumors
    Gyulai, Marton
    Megyesfalvi, Zsolt
    Reiniger, Lilla
    Harko, Tunde
    Ferencz, Bence
    Karsko, Luca
    Agocs, Laszlo
    Fillinger, Janos
    Dome, Balazs
    Szallasi, Zoltan
    Moldvay, Judit
    PATHOLOGY & ONCOLOGY RESEARCH, 2023, 29
  • [9] Expression of PD-1/PD-L1 in lung adenocarcinoma and its clinical significance
    Jian Li
    Yimin Chen
    OncologyandTranslationalMedicine, 2021, 7 (01) : 15 - 19
  • [10] Prognostic value of PD-L1 and PD-1 expression in pulmonary neuroendocrine tumors
    Fan, Yangwei
    Ma, Ke
    Wang, Chuying
    Ning, Jing
    Hu, Yuan
    Dong, Danfeng
    Dong, Xuyuan
    Geng, Qianqian
    Li, Enxiao
    Wu, Yinying
    ONCOTARGETS AND THERAPY, 2016, 9 : 6075 - 6082
12345